ESPE Abstracts

Cancer treatment may result in development of long-term endocrine complications, including growth hormone (GH) deficiency.1 Although extensive and careful monitoring has been carried out to establish the safety profile of GH therapy,2 a relative scarcity of data means that questions persist around its use in survivors of childhood cancer. The effects of GH on growth and metabolism mean that there is a particular interest in whether GH therapy increases th...

Endocrine and reproductive sequelae are among the most commonly reported complications in survivors of childhood cancer and brain tumors with nearly 50% individuals affected. Treatment related hormonal disorders may occur in a delayed fashion as late effects, several years to decades after the completion of cancer or tumor therapy, especially when resulting from the irradiation of the endocrine glands. This phenomenon requires a systematic, risk-based, approach in the screenin...

Fertility is dependent on the normal development of germ cells, which is controlled by hormones and paracrine factors produced by the somatic cells within the gonads. However, exposure to cancer treatment during childhood can cause damage to the gonads leading to infertility in adulthood [1]. This presentation will explore how various cancer treatments affect gonadal function based on clinical evidence in patients [2], experimental models involving animals and studies utilisin...